September 22, 2017

Lysogene Holds First Parent Advisory Board in MPS IIIA

Lysogene (FR0013233475 – LYS) (Paris:LYS), a leading, biopharmaceutical company pioneering gene therapy technologies to treat central nervous system diseases, today announced the first meeting of the Parent Advisory Board for parents and caregivers of children with Mucopolysaccharidosis Type IIIA (MPS IIIA), also […]
August 31, 2017

CISCRP Collaborates with Sanofi to Educate Community on Clinical Trials

CISCRP is delighted to announce the upcoming AWARE for All clinical research education and health fair event that will take place in Newark, NJ. The event will be held on Thursday, September 28, 2017 from 5:00 p.m. – 8:00 p.m. at the […]
June 27, 2017

CISCRP Recognizes WIRB-Copernicus Group’s Support and Donation to Clinical Trial Awareness and Education

The Center for Information and Study on Clinical Research Participation(CISCRP), an independent, non-profit organization dedicated to educating patients and the public about clinical research is pleased to thank and recognize WIRB-Copernicus Group® (WCG) for its recent support of CISCRP’s Medical Heroes 5K […]
June 19, 2017

CISCRP Supports Lilly’s Hero’s Journey Art Project to Honor Clinical Trial Participants

The Center for Information and Study on Clinical Research Participation (CISCRP), an independent non-profit organization dedicated to educating patients and the public about clinical research is excited to announce support of Eli Lilly and Company’s (Lilly) Hero’s Journey Art Project, a series […]